AOP Orphan Pharmaceuticals GmbH is a member company of the Association of the Austrian Pharmaceutical Industry (“PHARMIG”) and, as such, adheres to the PHARMIG Code of Conduct, which can be accessed here.
PUBLICATION AND DISCLOSURE OF ALL MONEY-VALUE SERVICES FROM THE CALENDAR YEAR 2021
As a member of the Association of the Austrian Pharmaceutical Industry, AOP Orphan Pharmaceuticals GmbH is committed to voluntary self-restraint through the PHARMIG Code of Conduct and fulfills its responsibility and obligation to disclose any Transfers of Value in accordance with the criteria of the PHARMIG Code of Conduct.
AOP Orphan Pharmaceuticals GmbH and its affiliated companies are convinced that transparent interactions with healthcare organizations, healthcare professionals, patient organizations and other specialist groups foster trust and avoid conflicts of interest from the outset.
Further information on the methodology of the transparency report and the corresponding disclosures can be found in the following documents:
Transparency report 2021 AFK & IFK (pdf)
Transparency report 2021 PTO (pdf)